| 2D Structure | |
| CID | 3371 |
| IUPAC Name | 2-[3-(trifluoromethyl)anilino]benzoic acid |
| InChI | InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20) |
| InChI Key | LPEPZBJOKDYZAD-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C14H10F3NO2 |
| Molecular Weight | 281.23 |
| synonyms | ['flufenamic acid', '530-78-9', 'Arlef', 'Fluphenamic acid', 'Achless', '2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid', 'N-(3-Trifluoromethylphenyl)anthranilic acid', 'Acido flufenamico', 'Flufenaminsaeure', 'Meralen', '2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid', 'Acide flufenamique', 'CI 440', 'NSC-82699', '2-[3-(Trifluoromethyl)anilino]benzoic acid', 'Acidum flufenamicum', '2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid', 'CN-27,554', "3'-Trifluoromethyldiphenylamine-2-carboxylic acid", 'INF-1837', 'Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-', 'DTXSID7023063', 'Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-', '60GCX7Y6BH', 'N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid', 'NSC-219007', 'CHEBI:42638', 'CI-440', 'CN-27554', 'DTXCID303063', 'Acid, Flufenamic', '2-(3-(trifluoromethyl)anilino)benzoic acid', 'flufenamic acid aluminium', 'RefChem:388982', 'M01AG03', '208-494-1', 'Fullsafe', 'Nichisedan', 'Tecramine', 'Paraflu', 'Parlef', 'Flufacid', 'Lanceat', 'Plostene', 'Parlif', 'Surika', 'Reumajust A', 'Ristogen', 'Sastridex', 'Ansatin', 'Fluore-200', 'ANT-1', 'MFCD00002422', 'TVX 916', 'INF 1837', 'C.I. 440', 'NSC 219007', '2-(3-Trifluoromethylanilino)benzoic Acid', 'N-[3-(Trifluoromethyl)phenyl]anthranilic acid', '2-((3-Trifluromethyl)phenyl)aminobenzoic acid', '2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID', 'N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid', 'CHEMBL23588', 'MLS000028563', 'Saal-F', 'NCGC00016490-06', 'CAS-530-78-9', 'SMR000059027', 'N-(3-Trifluoromethylphenyl)-anthranilic acid', 'WLN: QVR BMR CXFFF', 'FFA', 'F0909-0007', 'Flufenamicacid', 'N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid', 'Flufenaminsaeure [German]', 'Acido flufenamico [Italian]', 'FLF', 'CCRIS 5266', '2-[(3-Trifluromethyl)phenyl]aminobenzoic acid', 'N-[(3-Trifluoromethyl)phenyl]anthranilic acid', 'Acide flufenamique [INN-French]', 'Acido flufenamico [INN-Spanish]', 'Acidum flufenamicum [INN-Latin]', 'N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid', 'N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid', 'N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid', 'SR-01000000241', 'EINECS 208-494-1', 'Anthranilic acid,.alpha.,.alpha.-trifluoro-m-tolyl)-', 'N-(.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid', 'UNII-60GCX7Y6BH', 'Flufenamic acid [USAN:INN:BAN:JAN]', 'BRN 1996069', 'flufenamic-acid', 'Prestwick_220', 'Arlef (TN)', 'Spectrum_001257', '1bm7', 'Opera_ID_578', 'Prestwick0_000203', 'Prestwick1_000203', 'Prestwick2_000203', 'Prestwick3_000203', 'Spectrum2_000789', 'Spectrum3_001273', 'Spectrum4_000102', 'Spectrum5_000686', 'Etofenamate EP Impurity A', 'Epitope ID:613429', 'EC 208-494-1', 'Flufenamic acid (Standard)', 'CBiol_001756', 'SCHEMBL17497', 'BSPBio_000185', 'BSPBio_001319', 'BSPBio_002866', 'CBDivE_012649', 'FLUFENAMIC ACID [MI]', 'KBioGR_000039', 'KBioGR_000424', 'KBioGR_002267', 'KBioSS_000039', 'KBioSS_001737', 'KBioSS_002268', '3-14-00-00905 (Beilstein Handbook Reference)', 'MLS001148610', 'DivK1c_000581', 'FLUFENAMIC ACID [INN]', 'FLUFENAMIC ACID [JAN]', 'SPECTRUM1501015', 'SPBio_000898', 'SPBio_002106', 'FLUFENAMIC ACID [USAN]', 'BPBio1_000205', 'GTPL2447', 'orb1310228', 'FLUFENAMIC ACID [MART.]', 'SCHEMBL29356958', 'BCBcMAP01_000039', 'BDBM17636', 'HMS501N03', 'HY-B1221R', 'KBio1_000581', 'KBio2_000039', 'KBio2_001737', 'KBio2_002267', 'KBio2_002607', 'KBio2_004305', 'KBio2_004835', 'KBio2_005175', 'KBio2_006873', 'KBio2_007403', 'KBio3_000077', 'KBio3_000078', 'KBio3_002366', 'KBio3_002747', 'Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-', 'FLUFENAMIC ACID [WHO-DD]', 'MSK8002', 'cMAP_000004', 'NINDS_000581', 'Bio1_000042', 'Bio1_000531', 'Bio1_001020', 'Bio2_000039', 'Bio2_000519', 'Flufenamic acid (JAN/USAN/INN)', 'GLXC-27023', 'HMS1361B21', 'HMS1568J07', 'HMS1791B21', 'HMS1921B21', 'HMS1989B21', 'HMS2089E07', 'HMS2092B09', 'HMS2095J07', 'HMS2232G24', 'HMS3371F01', 'HMS3402B21', 'HMS3652F06', 'HMS3712J07', 'HMS3885P15', 'HMS5082J22', 'Pharmakon1600-01501015', 'SMSSF-0062312', 'HY-B1221', 'NSC82699', 'Tox21_110452', 'Tox21_302111', 'CCG-40167', 'EBC-04210', 'MSK8002-100A', 'NSC219007', 'NSC757823', 's4268', 'SBB001140', 'STK985630', 'AKOS000265536', 'MSK8002-1000A', 'Tox21_110452_1', 'CS-4811', 'DB02266', 'FF23323', 'KS-1143', 'NSC-757823', 'Etofenamate EP Impurity A (Free Base)', 'IDI1_000581', 'IDI1_033789', 'NCGC00016490-01', 'NCGC00016490-02', 'NCGC00016490-03', 'NCGC00016490-04', 'NCGC00016490-05', 'NCGC00016490-07', 'NCGC00016490-08', 'NCGC00016490-09', 'NCGC00016490-10', 'NCGC00016490-12', 'NCGC00023200-03', 'NCGC00023200-04', 'NCGC00023200-05', 'NCGC00023200-06', 'NCGC00023200-07', 'NCGC00255175-01', 'CN-27544', 'ST026563', 'SY014664', 'SBI-0051633.P002', 'DB-052254', '2-[3-(trifluoromethyl)anilino]-benzoic acid', 'AB00052198', 'ETOFENAMATE IMPURITY A [EP IMPURITY]', 'n-(a,a,a-trifluoro-m-tolyl)anthranilic acid', 'NS00000475', 'SW196528-3', 'T2354', 'UNM000001246003', '2-[3-(Trifluoromethyl)anilino]benzoic acid #', 'EN300-16858', 'o-[m-(trifluoromethyl)phenylamino]benzoic acid', '2-[(3-Trifluoromethylphenyl)amino]benzoic Acid', 'D01581', 'D97458', 'AB00052198-14', 'AB00052198_15', 'F358173', 'Q416341', "3'-Trifluoromethyldiphenylamine-2-carbox ylic acid", 'Flufenamic acid Solution in Acetonitrile, 100ug/mL', 'SR-01000000241-2', 'SR-01000000241-3', 'BRD-K44067360-001-06-3', 'BRD-K44067360-001-16-2', 'BRD-K44067360-001-29-5', 'BRD-K44067360-001-30-3', 'Flufenamic acid Solution in Acetonitrile, 1000ug/mL', 'Z56797275', 'Flufenamic acid, analytical standard, for drug analysis', 'Anthranilic acid, N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-', "FFA, Flufenamic acid, 3-[(2-Carboxyphenyl)amino]benzotrifluoride, 2-Carboxy-3'-(trifluoromethyl)diphenylamine"] |
From Pubchem